Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Arterial Lines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05821361
What this trial is testing

HAIC Combined With Cadonilimab and Bevacizumab as First-line Therapy in Unresectable Hepatocellular Carcinoma

Who this might be right for
Unrescetable Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Study completedNCT03527381
What this trial is testing

Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery

Who this might be right for
Coronary Artery DiseaseHeart Valve DiseasesCardiomyopathies+1 more
Nikolay Kamenshchikov 96
Not applicableLooking for participantsNCT07754656
What this trial is testing

Adapted Cardiopulmonary Resuscitation Study

Who this might be right for
Cardiac Arrest (CA)
Johannes Kepler University of Linz 216
Testing effectiveness (Phase 2)UnknownNCT06285019
What this trial is testing

Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 65
Testing effectiveness (Phase 2)WithdrawnNCT03069950
What this trial is testing

Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver

Who this might be right for
Colorectal Adenocarcinoma Metastatic to the Liver
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07557914
What this trial is testing

Epalrestat Combined With HAIC, Donafenib and Tislelizumab as First-line Treatment for Patients With Unresectable HCC and Diabetes

Who this might be right for
HCC - Hepatocellular CarcinomaDiabetes
Haibo Shao 32
Not applicableStudy completedNCT04456179
What this trial is testing

Continuous Non-Invasive Blood Pressure System Data Collection in Comparison to Invasive Radial Arterial Pressure

Who this might be right for
Blood Pressure Measurement
Sensifree Ltd. 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07584018
What this trial is testing

The DoHAICs Study Expansion Phase

Who this might be right for
HCC - Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT07646717
What this trial is testing

Efficacy and Safety of HAIC Combined With Lenvatinib and PD-1 Inhibitors for Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableStudy completedNCT03849183
What this trial is testing

Subcutaneous Nitroglycerin for Pediatric Radial Artery Cannulation

Who this might be right for
Arterial Line
Seoul National University Hospital 116
Not applicableStudy completedNCT01672073
What this trial is testing

Analysis of the Arterial Pressure Wave Form Through the Proxima Device

Who this might be right for
Local Pressure Effects
Sphere Medical Ltd. 10
Not applicableUnknownNCT06491589
What this trial is testing

Feasibility and Outcomes of Endovascular Aneurysm Repairs (EVARs) Without Arterial Line Monitoring

Who this might be right for
Abdominal Aortic Aneurysm
Nova Scotia Health Authority 100
Testing effectiveness (Phase 2)UnknownNCT05166772
What this trial is testing

Donafenib Combine With Sintilimab and HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）in the First-line Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Post-approval studies (Phase 4)Study completedNCT00349895
What this trial is testing

Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth

Who this might be right for
Coronary Artery DiseaseCoronary Artery Stenosis
OrbusNeich 100
Not applicableStudy completedNCT04132453
What this trial is testing

Continuous Blood Pressure and Waveform Measurements Comparison Between Invasive Arterial Line and PPG Sensor

Who this might be right for
Blood Pressure Measurement
Sensifree Ltd. 100
Testing effectiveness (Phase 2)Looking for participantsNCT07776080
What this trial is testing

Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Who this might be right for
HCC - Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 35
Not applicableStudy completedNCT03603860
What this trial is testing

Comparison of the Non-invasive Biobeat Device With an Invasive Arterial Line

Who this might be right for
Blood PressureHeart Diseases
Biobeat Technologies Ltd. 18
Post-approval studies (Phase 4)Ended earlyNCT02968901
What this trial is testing

Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA)

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 46
Large-scale testing (Phase 3)UnknownNCT05647954
What this trial is testing

HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the Liver

Who this might be right for
Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms
Taizhou Hanzhong biomedical co. LTD 350
Not applicableEnded earlyNCT02557828
What this trial is testing

Target Sign vs Palpation for Radial Arterial Line Placement

Who this might be right for
Radial Artery Cannulation
University of Iowa 260
Next Page